As states tighten oversight, private equity’s healthcare deals decline

New state oversight laws are slowing private equity’s involvement in healthcare, leading to a decline in both the number and value of such deals. According to data from Pitchbook, the industry is facing tighter scrutiny due to at least 25 states passing or proposing new laws that limit corporate control over medical practices. These regulations have made transactions more complex and expensive for private equity firms.